Organon & Co. OGN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.75% | -2.26% | -3.50% | -5.34% | 1.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.75% | -2.26% | -3.50% | -5.34% | 1.26% |
| Cost of Revenue | -3.82% | 1.43% | 1.06% | 6.47% | 11.23% |
| Gross Profit | 0.00% | -5.15% | -7.06% | -14.51% | -5.85% |
| SG&A Expenses | 1.45% | -4.19% | 0.95% | -6.10% | -1.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.87% | -1.12% | 0.68% | -1.71% | 3.36% |
| Operating Income | -1.35% | -6.38% | -18.26% | -20.52% | -5.13% |
| Income Before Tax | 4.94% | -20.09% | 110.89% | -214.73% | 17.39% |
| Income Tax Expenses | 9.64% | -10.71% | 378.57% | 185.00% | 154.61% |
| Earnings from Continuing Operations | 2.50% | -25.52% | 67.82% | -288.07% | -55.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.50% | -25.52% | 67.82% | -288.07% | -55.43% |
| EBIT | -1.35% | -6.38% | -18.26% | -20.52% | -5.13% |
| EBITDA | -3.25% | -7.14% | -14.11% | -11.46% | 0.65% |
| EPS Basic | 1.48% | -26.26% | 66.18% | -286.26% | -55.86% |
| Normalized Basic EPS | 2.89% | -16.85% | -16.65% | -31.54% | -2.11% |
| EPS Diluted | -1.64% | -28.29% | 66.67% | -291.42% | -55.80% |
| Normalized Diluted EPS | -0.54% | -19.20% | -16.44% | -30.95% | -1.51% |
| Average Basic Shares Outstanding | 1.02% | 1.03% | 0.97% | 0.96% | 0.96% |
| Average Diluted Shares Outstanding | 4.50% | 3.96% | 0.73% | 0.11% | 0.34% |
| Dividend Per Share | 0.00% | 0.00% | -92.86% | -92.86% | -92.86% |
| Payout Ratio | 0.63% | -0.19% | -0.96% | -1.03% | -0.91% |